vs
GRAN TIERRA ENERGY INC.（GTE）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是GRAN TIERRA ENERGY INC.的1.7倍（$207.3M vs $124.4M），Ultragenyx Pharmaceutical Inc.净利率更高（-62.0% vs -113.4%，领先51.4%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs -15.5%），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs -11.1%）
Gran Tierra Energy是一家2005年5月成立的能源企业，总部位于加拿大阿尔伯塔省卡尔加里，业务核心聚焦南美地区的油气勘探、开发与生产，曾于2008年7月宣布计划与Solana Resources完成合并。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
GTE vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $124.4M | $207.3M |
| 净利润 | $-141.1M | $-128.6M |
| 毛利率 | — | — |
| 营业利润率 | -142.9% | -54.7% |
| 净利率 | -113.4% | -62.0% |
| 营收同比 | -15.5% | 25.9% |
| 净利润同比 | -312.6% | 3.5% |
| 每股收益（稀释后） | $-3.98 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $124.4M | $207.3M | ||
| Q3 25 | $149.3M | $159.9M | ||
| Q2 25 | $152.5M | $166.5M | ||
| Q1 25 | $170.5M | $139.3M | ||
| Q4 24 | $147.3M | $164.6M | ||
| Q3 24 | $151.4M | $139.5M | ||
| Q2 24 | $165.6M | $147.0M | ||
| Q1 24 | $157.6M | $108.8M |
| Q4 25 | $-141.1M | $-128.6M | ||
| Q3 25 | $-19.9M | $-180.4M | ||
| Q2 25 | $-12.7M | $-115.0M | ||
| Q1 25 | $-19.3M | $-151.1M | ||
| Q4 24 | $-34.2M | $-133.2M | ||
| Q3 24 | $1.1M | $-133.5M | ||
| Q2 24 | $36.4M | $-131.6M | ||
| Q1 24 | $-78.0K | $-170.7M |
| Q4 25 | -142.9% | -54.7% | ||
| Q3 25 | -20.9% | -106.9% | ||
| Q2 25 | -5.3% | -64.8% | ||
| Q1 25 | -9.2% | -102.6% | ||
| Q4 24 | -14.9% | -74.3% | ||
| Q3 24 | 14.5% | -94.6% | ||
| Q2 24 | 16.5% | -79.1% | ||
| Q1 24 | 11.0% | -151.9% |
| Q4 25 | -113.4% | -62.0% | ||
| Q3 25 | -13.4% | -112.8% | ||
| Q2 25 | -8.4% | -69.0% | ||
| Q1 25 | -11.3% | -108.5% | ||
| Q4 24 | -23.2% | -80.9% | ||
| Q3 24 | 0.7% | -95.7% | ||
| Q2 24 | 22.0% | -89.5% | ||
| Q1 24 | -0.0% | -156.8% |
| Q4 25 | $-3.98 | $-1.28 | ||
| Q3 25 | $-0.57 | $-1.81 | ||
| Q2 25 | $-0.36 | $-1.17 | ||
| Q1 25 | $-0.54 | $-1.57 | ||
| Q4 24 | $-1.10 | $-1.34 | ||
| Q3 24 | $0.04 | $-1.40 | ||
| Q2 24 | $1.16 | $-1.52 | ||
| Q1 24 | $0.00 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $82.9M | $421.0M |
| 总债务越低越好 | $686.5M | — |
| 股东权益账面价值 | $228.7M | $-80.0M |
| 总资产 | $1.6B | $1.5B |
| 负债/权益比越低杠杆越低 | 3.00× | — |
8季度趋势，按日历期对齐
| Q4 25 | $82.9M | $421.0M | ||
| Q3 25 | $49.1M | $202.5M | ||
| Q2 25 | $61.0M | $176.3M | ||
| Q1 25 | $76.6M | $127.1M | ||
| Q4 24 | $103.4M | $174.0M | ||
| Q3 24 | $277.6M | $150.6M | ||
| Q2 24 | $115.3M | $480.7M | ||
| Q1 24 | $126.6M | $112.3M |
| Q4 25 | $686.5M | — | ||
| Q3 25 | $761.8M | — | ||
| Q2 25 | $772.6M | — | ||
| Q1 25 | $726.3M | — | ||
| Q4 24 | $722.1M | — | ||
| Q3 24 | $718.4M | — | ||
| Q2 24 | $582.1M | — | ||
| Q1 24 | $583.1M | — |
| Q4 25 | $228.7M | $-80.0M | ||
| Q3 25 | $366.0M | $9.2M | ||
| Q2 25 | $389.8M | $151.3M | ||
| Q1 25 | $393.8M | $144.2M | ||
| Q4 24 | $413.6M | $255.0M | ||
| Q3 24 | $420.9M | $346.8M | ||
| Q2 24 | $420.9M | $432.4M | ||
| Q1 24 | $392.0M | $140.3M |
| Q4 25 | $1.6B | $1.5B | ||
| Q3 25 | $1.7B | $1.2B | ||
| Q2 25 | $1.7B | $1.3B | ||
| Q1 25 | $1.7B | $1.3B | ||
| Q4 24 | $1.7B | $1.5B | ||
| Q3 24 | $1.5B | $1.5B | ||
| Q2 24 | $1.4B | $1.6B | ||
| Q1 24 | $1.4B | $1.3B |
| Q4 25 | 3.00× | — | ||
| Q3 25 | 2.08× | — | ||
| Q2 25 | 1.98× | — | ||
| Q1 25 | 1.84× | — | ||
| Q4 24 | 1.75× | — | ||
| Q3 24 | 1.71× | — | ||
| Q2 24 | 1.38× | — | ||
| Q1 24 | 1.49× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $157.2M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | — | $-100.8M |
| 自由现金流率自由现金流/营收 | — | -48.6% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $157.2M | $-99.8M | ||
| Q3 25 | $48.1M | $-91.4M | ||
| Q2 25 | $34.7M | $-108.3M | ||
| Q1 25 | $73.2M | $-166.5M | ||
| Q4 24 | $26.6M | $-79.3M | ||
| Q3 24 | $78.7M | $-67.0M | ||
| Q2 24 | $73.2M | $-77.0M | ||
| Q1 24 | $60.8M | $-190.7M |
| Q4 25 | — | $-100.8M | ||
| Q3 25 | — | $-92.7M | ||
| Q2 25 | — | $-110.7M | ||
| Q1 25 | — | $-167.8M | ||
| Q4 24 | — | $-79.5M | ||
| Q3 24 | — | $-68.6M | ||
| Q2 24 | — | $-79.0M | ||
| Q1 24 | — | $-193.9M |
| Q4 25 | — | -48.6% | ||
| Q3 25 | — | -58.0% | ||
| Q2 25 | — | -66.5% | ||
| Q1 25 | — | -120.5% | ||
| Q4 24 | — | -48.3% | ||
| Q3 24 | — | -49.2% | ||
| Q2 24 | — | -53.7% | ||
| Q1 24 | — | -178.2% |
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 1.5% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 1.4% | ||
| Q1 24 | — | 3.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 69.42× | — | ||
| Q2 24 | 2.01× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GTE
| Colombia Segment | $89.1M | 72% |
| Other | $22.9M | 18% |
| Ecuador Segment | $12.5M | 10% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
